AliMed, Inc. Awarded Vizient Contract for Radiation Protection Products

1 year ago

Dedham, Massachusetts--(Newsfile Corp. - September 3, 2024) - AliMed, Inc., a Massachusetts-based medical supply manufacturer and distributor, has been awarded…

Masimo Urges Stockholders to Vote “FOR” Only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy Card Today

1 year ago

Shares Details From Recently Unredacted Legal Filings About Quentin Koffey’s Multi-Year Plan to Take Control of MasimoIRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation…

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

1 year ago

Regulatory approval enables entry of Auryon Atherectomy System in European marketLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative…

Butterfly Network Appoints Steve Cashman as Chief Business Officer

1 year ago

Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial MomentumBURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--$BFLY #POCUS--Butterfly Network, Inc.…

Red Light Holland Launches FarmCare Health to Revolutionize Healthcare with Farm-Fresh Food Prescriptions

1 year ago

Our Mission:Our mission is to revolutionize healthcare by prescribing nutritious farm-fresh food, including our fresh mushrooms and mushroom home grow…

Kronos Bio Announces Participation in Medical and Investor Conferences in September

1 year ago

SAN MATEO, Calif., and CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated…

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX Congress

1 year ago

ST. LOUIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for…

Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

1 year ago

ISELIN, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval…

Y-mAbs to Participate in Upcoming Investor Conferences in September

1 year ago

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical…

Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference

1 year ago

AUSTIN, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s…